Zika

Zika-related Filings:

23 January 2017. MSF file comments with the US Army in opposition to the grant of an exclusive license to patents on a new vaccine for the Zika Virus.

12 January 2017. Comments filed by KEI and 5 other groups. "An exclusive license to patents on a new Zika vaccine to Sanofi is contrary to the provisions of 35 U.S.C. 209(a)(1)." Submitted to Federal Register notice (81 FR 89087) posted 9 December 2016, titled "Intent to Grant an Exclusive License of U.S. Government-Owned Patents."

21 December 2016. KEI Initial Comments regarding Department of the Army Intent to Grant an Exclusive License of US Governement-Owned Patents for patents on Zika Virus Vaccine and Methods of Production to Sanofi Pasteur, Inc..

9 December 2016. KEI request for information submitted to Barry Datloff, Office of Research & Technology Assessment, Department of the Army.

KEI Blogs:

12 January 2017. "Groups Object to Army Proposal to Give Sanofi a Monopoly on Patents for Taxpayer-Funded Zika Vaccine." James Love.

21 December 2016. "KEI initial opposition to U.S. Army grant of exclusive license to Sanofi on patents for Zika virus vaccine." KEI Staff.

2 March 2016. "DHHS Declared public health emergency for Zika virus." James Love.

Federal Register Notices:

9 December 2016. Federal Register Notice, "Intent to Grant an Exclusive License of U.S. Government-Owned Patents." Department of the Army. Citation: 81 FR 89087.

11 January 2017. Federal Register Notice, Comment Period Extension: "Intent to Grant an Exclusive License of U.S. Government-owned Patents." Citation: 82 FR 3295.

AttachmentSize
msf_comments_to_fr_notice_re_zika_vaccine_candidate_licensing.pdf369.8 KB